Article
Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype.
Diabetes - 1 Oct 1999
Flamez D, Gilon P, Moens K, Van Breusegem A, Delmeire D, Scrocchi L A, Henquin J C, Drucker D J, Schuit F
Abstract excerpt
1-Cells from rodents and humans express different receptors recognizing hormones of the secretin-glucagon family, which--when activated--synergize with glucose in the control of insulin release. We have recently reported that isolated islets from mice homozygous for a GLP-1 receptor null mutation (GLP-1R(-/-)) exhibit a well-preserved insulin-secretory response to glucose. This observation can be interpreted in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
